Danaher Corporation (LON:0R2B)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 114.23B |
| Revenue (ttm) | 17.51B |
| Net Income (ttm) | 2.49B |
| Shares Out | n/a |
| EPS (ttm) | 3.44 |
| PE Ratio | 45.90 |
| Forward PE | 26.16 |
| Dividend | 0.69 (0.32%) |
| Ex-Dividend Date | Sep 26, 2025 |
| Volume | 1,953 |
| Average Volume | 6,493 |
| Open | 211.70 |
| Previous Close | 211.18 |
| Day's Range | 210.21 - 219.76 |
| 52-Week Range | 171.02 - 280.17 |
| Beta | 0.78 |
| RSI | 67.53 |
| Earnings Date | Oct 21, 2025 |
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man... [Read more]
Financial Performance
In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.
Financial numbers in USD Financial StatementsNews
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
NEW YORK, Oct. 04, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher ...
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
NEW YORK , Oct. 3, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corp...
November 14th Options Now Available For Danaher Corp (DHR)
Investors in Danaher Corp (Symbol: DHR) saw new options become available today, for the November 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DHR option...
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher ...
Danaher: Balanced Portfolio With Upside Potential In 2026
Danaher Corporation is undervalued, with strong fundamentals, robust free cash flow, and 12.7% upside. Click here to read why DHR stock is a Buy.
SCHG, DHR, KKR, TT: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab U.S. Large-Cap Growth ETF (Symbol: SCHG) where we have detected...
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher...
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
NEW YORK , Sept. 26, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Co...
A Look Into Danaher Inc's Price Over Earnings
In the current market session, Danaher Inc. (NYSE: DHR) price is at $183.36, after a 1.05% spike. However, over the past month, the stock fell by 10.91% , and in the past year, by 34.05% . Shareholde...
DHR November 7th Options Begin Trading
Investors in Danaher Corp (Symbol: DHR) saw new options become available today, for the November 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DHR options...
DHR Factor-Based Stock Analysis
Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Multi-Factor Investor model based on the published strategy of Pim v...
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
NEW YORK , Sept. 23, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Co...
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher...
Danaher Schedules Third Quarter 2025 Earnings Conference Call
WASHINGTON , Sept. 23, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2025 on Tuesday, October 21, 202...
B of A Securities Adjusts Danaher (DHR) Price Target to $220 | DHR Stock News
B of A Securities Adjusts Danaher (DHR) Price Target to $220 | DHR Stock News
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
NEW YORK, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher...
UPRO, DHR, MDT, DE: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro S&P 500 (Symbol: UPRO) where we have detected an ap...
Danaher's Life Sciences Segment Shrinks: What's the Path Forward?
DHR's Life Sciences unit faces revenue declines from weak demand, but new products and biotech advances offer growth potential.
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
NEW YORK , Sept. 15, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher C...
Validea Detailed Fundamental Analysis - DHR
Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Multi-Factor Investor model based on the published strategy of Pim v...
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher...
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
NEW YORK , Sept. 10, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Co...
Danaher Corporation (DHR) Announces Amendments to By-laws and New Share Repurchase Program
Danaher Corporation (DHR) Announces Amendments to By-laws and New Share Repurchase Program
Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research
Beckman Coulter Also Announces Development of Aß-42 Research Use Only Immunoassay Test BREA, Calif. , Sept. 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a Danaher company and a leader in glob...
Danaher (DHR) Declares Quarterly Dividend, Updates Full-Year EPS Guidance
Danaher (DHR) Declares Quarterly Dividend, Updates Full-Year EPS Guidance